Macular Edema - Pipeline Review, H2 2014

Global Markets Direct
August 25, 2014
59 Pages - SKU: GMD5319403
Carnitine Palmitoyltransferase I (CPT 1) Inhibitors -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
Carnitine Palmitoyltransferase I (CPT 1) Inhibitors -Pipeline Insights, 2014 SUMMARY DelveInsight’s,“Carnitine Palmitoyltransferase I (CPT 1) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report  |  read more...
USD 1,250
Caspases Activators -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
Caspases Activators -Pipeline Insights, 2014 SUMMARY DelveInsight’s,“Caspases Activators-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the  |  read more...
USD 1,250
Caspases Inhibitors -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
Caspases Inhibitors -Pipeline Insights, 2014 SUMMARY DelveInsight’s,“Caspases Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the  |  read more...
USD 1,250
Cathepsin K Inhibitors -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
Cathepsin K Inhibitors -Pipeline Insights, 2014 SUMMARY DelveInsight’s,“Cathepsin K Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for  |  read more...
USD 1,250
CCR1 Inhibitors -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
CCR1 Inhibitors -Pipeline Insights, 2014 SUMMARY DelveInsight’s,“CCR1 Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the  |  read more...
USD 1,250
Bone Degeneration - Pipeline Review, H2 2014
11/14/2014 | published by: Global Markets Direct
Bone Degeneration - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Bone Degeneration - Pipeline Review, H2 2014’, provides an overview of the Bone Degeneration’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Bone  |  read more...
USD 2,000
Memory Impairment - Pipeline Review, H2 2014
11/14/2014 | published by: Global Markets Direct
Memory Impairment - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Memory Impairment - Pipeline Review, H2 2014’, provides an overview of the Memory Impairment’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Memory  |  read more...
USD 2,000
Cataract - Pipeline Review, H2 2014
11/14/2014 | published by: Global Markets Direct
Cataract - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Cataract - Pipeline Review, H2 2014’, provides an overview of the Cataract’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Cataract, complete with comparative  |  read more...
USD 2,000
Arterial Thrombosis - Pipeline Review, H2 2014
11/14/2014 | published by: Global Markets Direct
Arterial Thrombosis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Arterial Thrombosis - Pipeline Review, H2 2014’, provides an overview of the Arterial Thrombosis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Arterial  |  read more...
USD 2,000
Cerebral Infarction (Brain Infarction) - Pipeline Review, H2 2014
11/14/2014 | published by: Global Markets Direct
Cerebral Infarction (Brain Infarction) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Cerebral Infarction (Brain Infarction) - Pipeline Review, H2 2014’, provides an overview of the Cerebral Infarction (Brain Infarction)’s therapeutic pipeline. This report provides comprehensive information  |  read more...
USD 2,000
 

SELECT A LICENSE

    Online Download  USD 2,000  
    Site License  USD 4,000  
    Global Site License  USD 6,000  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!